CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD
10.10
-0.13 (-1.27%)
Apr 17, 2026, 4:08 PM HKT
Revenue by Segment
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 269.58M | 407.21M | 463.84M | 481.36M | 243.72M | | | | | |
| -33.80% | -12.21% | -3.64% | 97.51% | -76.54% | | | | | |
| 269.58M | 407.21M | 463.84M | 481.36M | 243.72M | | | | | |
| -33.80% | -12.21% | -3.64% | 97.51% | -76.54% | | | | | |
Revenue by Geography
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 83.84M | 293.36M | 370.23M | - | - | | | | | |
| -71.42% | -20.76% | - | - | - | | | | | |
| 185.74M | 113.85M | 93.61M | - | - | | | | | |
Outside Mainland China Growth | 63.14% | 21.62% | - | - | - | | | | | |
PRC (Excluding Hong Kong and Taiwan) | - | - | - | 476.53M | 243.72M | | | | | |
PRC (Excluding Hong Kong and Taiwan) Growth | - | - | - | 95.52% | - | | | | | |
| - | - | - | 4.84M | - | | | | | |
| 269.58M | 407.21M | 463.84M | 481.36M | 243.72M | | | | | |
| -33.80% | -12.21% | -3.64% | 97.51% | -76.54% | | | | | |
Source: S&P Global Market Intelligence.
